APPLICATION
ANDA210322
TYPE
ANDA
ORIGINAL APPROVAL
2018-06-12
LATEST ACTION
2023-09-05
ROUTE
INTRACARDIAC, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ISOPROTERENOL HYDROCHLORIDEDiscontinued
ISOPROTERENOL HYDROCHLORIDE 0.2MG/ML · INJECTABLE · INJECTION
Approval history
2023-09-05Labeling · Supplement 2 · standardAP
2018-06-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.